ELVN
#1679
Enliven Therapeutics, Inc. - Common Stock
50.8 7 USD
0.00%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.43%
Variación mensual
+11.48%
Variación en los últimos 6 meses
+94.23%
Cambio anual
+146.22%
Cierres anteriores
51.0 9
Open
50.8 7
Mínimo
50.8 7
High
50.8 7
Volumen
74
Financials
- Market Capitalization 3.1 B
- Employee 61
- Founded 2016
- CEO N/A
- Website www.enliventherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00CP3BDD4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-8.42
Relación precio/flujo de caja
-8 232.35
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1661 |  BEAM Beam Therapeutics Inc. - Common Stock | 31.00 USD | -5.14% | -15.07% | +3.85% | +45.27% | 3.19 B USD | ||
| 1663 |  IDYA IDEAYA Biosciences, Inc. - Common Stock | 36.15 USD | -2.27% | -7.85% | +22.83% | +10.96% | 3.18 B USD | ||
| 1701 |  CLDX Celldex Therapeutics, Inc. - Common Stock | 38.53 USD | -1.48% | +1.39% | +21.47% | +41.45% | 3.02 B USD | ||
| 1713 |  VERA Vera Therapeutics, Inc. - Class A Common Stock | 41.50 USD | -1.19% | +3.03% | +19.70% | +39.54% | 2.98 B USD |